Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Stomach Cancer Clinical Research Samples
Discovery Life Sciences provides the highest quality Stomach Cancer Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Stomach Cancer Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 46 of 46 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Detail 3 | Product Details | Price | Buy | Blood Type | Co-morbidities | Consent Status Date | Current Medications | Height | Weight | Menopausal Status | Smoking Notes | ICD10 codes | Site of Primary Tumor | History of Benign Disease Prior to Cancer Diagnosis | Site of Metastasis | Any Previous Form of Cancer | Biomarker Testing Information | Esophagogastroduodenoscopy | X-Ray | Biopsy | HIV-I/II | HBC | HCV Result | Alcohol Consumption | Surgical Procedure | Tumor Information | Microscopic description | Conclusion of the pathologist |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBS0000-CV900097980101416DD | Stomach Cancer | Vietnam | Serum | 1.00 | 1.00 | $150.00 | 57 Y | Female | Non-Hispanic | <-70C | 14-Oct-16 | Clinical Diagnosis | Stomach Cancer | Staging | Tumor T0 | Additional Information | Stomach cancer peritoneal metastasis was diagnosed 01/2016. Cell: ring cell carcinoma. | $150.00 | Unknown | Menopausal | Non-smoker | Stomach | No | ||||||||||||||||||||||||
| BBS0000-CV900398758030619D4 | Stomach Cancer | Vietnam | Serum | 0.35 | 3.00 | $150.00 | 63 Y | Male | Non-Hispanic | <-70C | 06-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | II; T2NXM0 | Date of Primary Tumor Diagnosis | 2019-03-04 | $150.00 | Unknown | 2019-03-06 | Nexium | 65.75 | 117 | Stomach | None | U/A | No | CA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 | | |||||||||||||||||||
| BBS0000-CV900398763030719DD | Stomach Cancer | Vietnam | Serum | 0.35 | 2.00 | $150.00 | 69 Y | Male | Non-Hispanic | <-70C | 07-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV; T3N3MX | Date of Primary Tumor Diagnosis | 2019-02-25 | $150.00 | Unknown | 2019-03-07 | Omeprazole, Amlodipine | 62.60 | 128 | Stomach | Hypertension | Lymph nodes | No | CEA: 3.75 U/mL | 19-Feb-2019 | | |||||||||||||||||||
| BBS0000-G2900365161112919DD | Stomach Cancer | Ukraine | Serum | 0.50 | 10.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 29-Nov-19 | Clinical Diagnosis | Cancer of the stomach, T1-2NxM0, stage II | Disease Status | Primary | Most Recent Staging | T3N0M0; IIA, G3 | Special Order. Please Inquire | Unknown | Essential hypertension, grade II | 2019-11-29 | 67.72 | 243 | Never used | Gastrointestinal tract | There is a neoplastic process of the stomach, an infiltrative form. 2019-11-14 | Stomach | There is a defect in the lower third of the body of the stomach with a transition to the antrum. 2019-11-20 | Stomach | There is a carcinoma, G3. 2019-11-19 | Negative 2019-11-29 | Never used | Subtotal gastrectomy | Stomach, NOS 2019-11-29 | Body of stomach 3.0 x 1.4 | Carcinoma of the stomach, G3. Tumor penetrates the subserosal connective tissue. There are signs of lymphovascular invasion. No perineural invasion. There are no metastases in the lymph nodes. | Carcinoma | ||||||||||||||
| EDP0000-AA900022548080319DD | Stomach Cancer | Russia | K2 EDTA Plasma | 1.25 | 2.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 03-Aug-19 | Clinical Diagnosis | Adenocarcinoma of Stomach | Endoscopy, Ultrasound and CT | Staging | Iib, T3N1M0G2 | 12-Aug-19 | Date of Initial Primary Tumor Diagnosis | 19-Jul-19 | $150.00 | Unknown | None | None | Former 10-15 cigs/day for over 10 years | C16.2 | Stomach | Chronic gastritis | N/A | No | ||||||||||||||||||
| EDP0000-AA900031115080419DD | Stomach Cancer | Russia | K2 EDTA Plasma | 1.00 | 2.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 04-Aug-19 | Clinical Diagnosis | Adenocarcinoma of Stomach | Endoscopy, Ultrasound, CT and MRI | Staging | Iib, T3NXM0G3 | 12-Aug-19 | Date of Initial Primary Tumor Diagnosis | 12-Jul-19 | $150.00 | Unknown | None | None | NA | C16.3 | Stomach | Gastric ulcer, Chronic gastroduodenitis | N/A | No | ||||||||||||||||||
| EDP0000-AA900037629062819DD | Stomach Cancer | Russia | K2 EDTA Plasma | 1.00 | 2.00 | $150.00 | 72 Y | Male | Non-Hispanic | <-70C | 28-Jun-19 | Clincal Diagnosis | Adenocarcinoma of Stomach | Most Recent Staging | Iia; T3N0M0G2 | 7-Jul-19 | Date of Initial Primary Tumor Diagnosis | 16-Jun-19 | $150.00 | Unknown | None | Unknown | Former 15-20 cigs/day for over 25 years | C16.2 | Stomach | Gastric ulcer | U/A | ||||||||||||||||||||
| EDP0000-AA900037631060519DD | Stomach Cancer | Russia | K2 EDTA Plasma | 1.00 | 2.00 | $150.00 | 51 Y | Female | Non-Hispanic | <-70C | 05-Jun-19 | Clinical Diagnosis | Adenocarcinoma of Stomach | Endoscopy, Ultrasound, CT and MRI | Staging | Iia, T2NXM0G3 | 16-Jun-19 | Date of Initial Primary Tumor Diagnosis | 20-May-19 | $150.00 | Unknown | None | None | Current 10-15 cigs/day for over 20 years | C16.1 | Stomach | No | N/A | No | ||||||||||||||||||
| EDP0000-AA900099086070219DD | Stomach Cancer | Russia | K2 EDTA Plasma | 1.00 | 2.00 | $150.00 | 60 Y | Female | Hispanic | <-70C | 02-Jul-19 | Clinical Diagnosis | Adenocarcinoma of Stomach | Endoscopy, CT and MRI | Staging | Iib, T1N2M0G3 | 11-Jul-19 | Date of Initial Primary Tumor Diagnosis | 27-Jun-19 | $150.00 | Unknown | Acute pneumonia | Amoxicillin, Clavulanate | Former 5-15 cigs/day for over 20 years | C16.4 | Stomach | Chronic gastroduodenitis | N/A | No | ||||||||||||||||||
| EDP0000-CV900095993032219DD | Stomach Cancer | Vietnam | K2 EDTA Plasma | 2.00 | $150.00 | 42 Y | Male | Non-Hispanic | <-70C | 22-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | T2NXMX | 14-Mar-19 | Additional Notes | Tumor pathology: adenocarcinoma. Endoscopy: ulcer and tumor in pylorus. CAT scan: cirrhosis, splenomegaly | $150.00 | Unknown | Omeprazole | Unknown | NA | Stomach | Cirrhosis by alcohol since 2016 | U/A | ||||||||||||||||||||||
| EDP0000-CV900096302031819DD | Stomach Cancer | Vietnam | K2 EDTA Plasma | 0.50 | 2.00 | $75.00 | 71 Y | Female | Non-Hispanic | <-70C | 18-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | N1M1 | Date N/A | Additional Notes | Endoscopy: tumor in stomach 1x1.5 cm, ucler. Pathology: adenocarcinoma. | $75.00 | Unknown | Omeprazole, Metformin | Postmenopausal | NA | Stomach | Hypertension, Diabetes | Abdominal lymph nodes | |||||||||||||||||||||
| EDP0000-CV900098050050419DD | Stomach Cancer | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $150.00 | 71 Y | Male | Non-Hispanic | <-70C | 04-May-19 | Clinical Diagnosis | Stomach Cancer (Gastric) | Staging | IV TXN3M1 | 11-May-19 | Additional Notes | Endoscopy: tumor in stomach. Pathology: adenocarcinoma. CT Scan: multiple lesions in neck max. 3.0x2.5 cm | $150.00 | Unknown | None | Unknown | NA | Stomach | Hypertension > 10 years | Liver, Lymph nodes | |||||||||||||||||||||
| EDP0000-CV900098054061819DD | Stomach Cancer | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $150.00 | 21 Y | Female | Non-Hispanic | <-70C | 18-Jun-19 | Clinical Diagnosis | Stomach Cancer | Staging | Iia T1bN2M0G3 | 3-Jun-19 | Additional Notes | Pathology: Adenocarcinoma. Endoscopy: ulcer 0.4 cm in stomach bulge. CT scan: normal | $150.00 | Unknown | Omeprazole | Premenopausal | NA | Stomach | None | Lymph nodes | |||||||||||||||||||||
| EDP0000-CV900098695040419DD | Stomach Cancer | Vietnam | K2 EDTA Plasma | 1.00 | 2.00 | $150.00 | 85 Y | Male | Non-Hispanic | <-70C | 04-Apr-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV T4N3M0G2 | 2-Apr-19 | Additional Notes | Pathology: Adenocarcinoma grade II. Endoscopy: tumor with ulcer | $150.00 | Unknown | None | Unknown | NA | Stomach | Hypertension | Abdominal lymph nodes | |||||||||||||||||||||
| EDP0000-CV900398757030819D5 | Stomach Cancer | Vietnam | K2 EDTA Plasma | 0.35 | 4.00 | $150.00 | 52 Y | Male | Non-Hispanic | <-70C | 08-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV; T4N3M1G4 | 2019-03-07 | Date of Primary Tumor Diagnosis | 2019-02-26 | $150.00 | Unknown | 2019-03-08 | Omeprazole, Ultracet | 69.69 | 163 | Stomach | Hypertension | Lymph node, Bone, Lung | No | CA 72-4: 1.35 U/mL | CA 19-9: 21.9 U/mL | CEA: 36.04 U/mL | 21-Feb-2019 | HBsAg - Positive | 19-Feb-2019 | | ||||||||||||||||||
| EDP0000-CV900398758030619D5 | Stomach Cancer | Vietnam | K2 EDTA Plasma | 0.35 | 4.00 | $150.00 | 63 Y | Male | Non-Hispanic | <-70C | 06-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | II; T2NXM0 | Date of Primary Tumor Diagnosis | 2019-03-04 | $150.00 | Unknown | 2019-03-06 | Nexium | 65.75 | 117 | Stomach | None | U/A | No | CA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 | | |||||||||||||||||||
| EDP0000-CV900398763030719D4 | Stomach Cancer | Vietnam | K2 EDTA Plasma | 0.35 | 3.00 | $150.00 | 69 Y | Male | Non-Hispanic | <-70C | 07-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV; T3N3MX | Date of Primary Tumor Diagnosis | 2019-02-25 | $150.00 | Unknown | 2019-03-07 | Omeprazole, Amlodipine | 62.60 | 128 | Stomach | Hypertension | Lymph nodes | No | CEA: 3.75 U/mL | 19-Feb-2019 | | |||||||||||||||||||
| LHP0000-CV900398757030819DD | Stomach Cancer | Vietnam | L. Heparin Plasma | 0.35 | 3.00 | $150.00 | 52 Y | Male | Non-Hispanic | <-70C | 08-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV; T4N3M1G4 | 2019-03-07 | Date of Primary Tumor Diagnosis | 2019-02-26 | $150.00 | Unknown | 2019-03-08 | Omeprazole, Ultracet | 69.69 | 163 | Stomach | Hypertension | Lymph node, Bone, Lung | No | CA 72-4: 1.35 U/mL | CA 19-9: 21.9 U/mL | CEA: 36.04 U/mL | 21-Feb-2019 | HBsAg - Positive | 19-Feb-2019 | | ||||||||||||||||||
| LHP0000-CV900398758030619DD | Stomach Cancer | Vietnam | L. Heparin Plasma | 0.35 | 4.00 | $150.00 | 63 Y | Male | Non-Hispanic | <-70C | 06-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | II; T2NXM0 | Date of Primary Tumor Diagnosis | 2019-03-04 | $150.00 | Unknown | 2019-03-06 | Nexium | 65.75 | 117 | Stomach | None | U/A | No | CA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 | | |||||||||||||||||||
| LHP0000-CV900398763030719D3 | Stomach Cancer | Vietnam | L. Heparin Plasma | 0.35 | 3.00 | $150.00 | 69 Y | Male | Non-Hispanic | <-70C | 07-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV; T3N3MX | Date of Primary Tumor Diagnosis | 2019-02-25 | $150.00 | Unknown | 2019-03-07 | Omeprazole, Amlodipine | 62.60 | 128 | Stomach | Hypertension | Lymph nodes | No | CEA: 3.75 U/mL | 19-Feb-2019 | | |||||||||||||||||||
| NAP0000-CV900398757030819DD | Stomach Cancer | Vietnam | S. Heparin Plasma | 0.35 | 3.00 | $150.00 | 52 Y | Male | Non-Hispanic | <-70C | 08-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV; T4N3M1G4 | 2019-03-07 | Date of Primary Tumor Diagnosis | 2019-02-26 | $150.00 | Unknown | 2019-03-08 | Omeprazole, Ultracet | 69.69 | 163 | Stomach | Hypertension | Lymph node, Bone, Lung | No | CA 72-4: 1.35 U/mL | CA 19-9: 21.9 U/mL | CEA: 36.04 U/mL | 21-Feb-2019 | HBsAg - Positive | 19-Feb-2019 | | ||||||||||||||||||
| NAP0000-CV900398758030619DD | Stomach Cancer | Vietnam | S. Heparin Plasma | 0.35 | 2.00 | $150.00 | 63 Y | Male | Non-Hispanic | <-70C | 06-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | II; T2NXM0 | Date of Primary Tumor Diagnosis | 2019-03-04 | $150.00 | Unknown | 2019-03-06 | Nexium | 65.75 | 117 | Stomach | None | U/A | No | CA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 | | |||||||||||||||||||
| NAP0000-CV900398763030719D3 | Stomach Cancer | Vietnam | S. Heparin Plasma | 0.35 | 3.00 | $150.00 | 69 Y | Male | Non-Hispanic | <-70C | 07-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV; T3N3MX | Date of Primary Tumor Diagnosis | 2019-02-25 | $150.00 | Unknown | 2019-03-07 | Omeprazole, Amlodipine | 62.60 | 128 | Stomach | Hypertension | Lymph nodes | No | CEA: 3.75 U/mL | 19-Feb-2019 | | |||||||||||||||||||
| NCP0000-G2900365161112919DD | Stomach Cancer | Ukraine | Na. Citrate Plasma | 0.50 | 1.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 29-Nov-19 | Clinical Diagnosis | Cancer of the stomach, T1-2NxM0, stage II | Disease Status | Primary | Most Recent Staging | T3N0M0; IIA, G3 | Special Order. Please Inquire | Unknown | Essential hypertension, grade II | 2019-11-29 | 67.72 | 243 | Never used | Gastrointestinal tract | There is a neoplastic process of the stomach, an infiltrative form. 2019-11-14 | Stomach | There is a defect in the lower third of the body of the stomach with a transition to the antrum. 2019-11-20 | Stomach | There is a carcinoma, G3. 2019-11-19 | Negative 2019-11-29 | Never used | Subtotal gastrectomy | Stomach, NOS 2019-11-29 | Body of stomach 3.0 x 1.4 | Carcinoma of the stomach, G3. Tumor penetrates the subserosal connective tissue. There are signs of lymphovascular invasion. No perineural invasion. There are no metastases in the lymph nodes. | Carcinoma | ||||||||||||||
| PST0000-CV900398757030819DD | Stomach Cancer | Vietnam | PST | 0.35 | 3.00 | $150.00 | 52 Y | Male | Non-Hispanic | <-70C | 08-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV; T4N3M1G4 | 2019-03-07 | Date of Primary Tumor Diagnosis | 2019-02-26 | $150.00 | Unknown | 2019-03-08 | Omeprazole, Ultracet | 69.69 | 163 | Stomach | Hypertension | Lymph node, Bone, Lung | No | CA 72-4: 1.35 U/mL | CA 19-9: 21.9 U/mL | CEA: 36.04 U/mL | 21-Feb-2019 | HBsAg - Positive | 19-Feb-2019 | | ||||||||||||||||||
| PST0000-CV900398758030619D3 | Stomach Cancer | Vietnam | PST | 0.35 | 4.00 | $150.00 | 63 Y | Male | Non-Hispanic | <-70C | 06-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | II; T2NXM0 | Date of Primary Tumor Diagnosis | 2019-03-04 | $150.00 | Unknown | 2019-03-06 | Nexium | 65.75 | 117 | Stomach | None | U/A | No | CA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 | | |||||||||||||||||||
| PST0000-CV900398763030719DD | Stomach Cancer | Vietnam | PST | 0.35 | 3.00 | $150.00 | 69 Y | Male | Non-Hispanic | <-70C | 07-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV; T3N3MX | Date of Primary Tumor Diagnosis | 2019-02-25 | $150.00 | Unknown | 2019-03-07 | Omeprazole, Amlodipine | 62.60 | 128 | Stomach | Hypertension | Lymph nodes | No | CEA: 3.75 U/mL | 19-Feb-2019 | | |||||||||||||||||||
| SST0000-AA900022548080319DD | Stomach Cancer | Russia | SST | 1.50 | 1.00 | $75.00 | 59 Y | Female | Non-Hispanic | <-70C | 03-Aug-19 | Clinical Diagnosis | Adenocarcinoma of Stomach | Endoscopy, Ultrasound and CT | Staging | Iib, T3N1M0G2 | 12-Aug-19 | Date of Initial Primary Tumor Diagnosis | 19-Jul-19 | $75.00 | Unknown | None | None | Former 10-15 cigs/day for over 10 years | C16.2 | Stomach | Chronic gastritis | N/A | No | ||||||||||||||||||
| SST0000-AA900037629062819DD | Stomach Cancer | Russia | SST | 0.75 | 1.00 | $75.00 | 72 Y | Male | Non-Hispanic | <-70C | 28-Jun-19 | Clincal Diagnosis | Adenocarcinoma of Stomach | Most Recent Staging | Iia; T3N0M0G2 | 7-Jul-19 | Date of Initial Primary Tumor Diagnosis | 16-Jun-19 | $75.00 | Unknown | None | Unknown | Former 15-20 cigs/day for over 25 years | C16.2 | Stomach | Gastric ulcer | U/A | ||||||||||||||||||||
| SST0000-AA900037631060519DD | Stomach Cancer | Russia | SST | 1.00 | 1.00 | $75.00 | 51 Y | Female | Non-Hispanic | <-70C | 05-Jun-19 | Clinical Diagnosis | Adenocarcinoma of Stomach | Endoscopy, Ultrasound, CT and MRI | Staging | Iia, T2NXM0G3 | 16-Jun-19 | Date of Initial Primary Tumor Diagnosis | 20-May-19 | $75.00 | Unknown | None | None | Current 10-15 cigs/day for over 20 years | C16.1 | Stomach | No | N/A | No | ||||||||||||||||||
| SST0000-AA900099086070219DD | Stomach Cancer | Russia | SST | 0.50 | 1.00 | $75.00 | 60 Y | Female | Hispanic | <-70C | 02-Jul-19 | Clinical Diagnosis | Adenocarcinoma of Stomach | Endoscopy, CT and MRI | Staging | Iib, T1N2M0G3 | 11-Jul-19 | Date of Initial Primary Tumor Diagnosis | 27-Jun-19 | $75.00 | Unknown | Acute pneumonia | Amoxicillin, Clavulanate | Former 5-15 cigs/day for over 20 years | C16.4 | Stomach | Chronic gastroduodenitis | N/A | No | ||||||||||||||||||
| SST0000-CV900095993032219DD | Stomach Cancer | Vietnam | SST | 1.00 | 1.00 | $150.00 | 42 Y | Male | Non-Hispanic | <-70C | 22-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | T2NXMX | 14-Mar-19 | Additional Notes | Tumor pathology: adenocarcinoma. Endoscopy: ulcer and tumor in pylorus. CAT scan: cirrhosis, splenomegaly | $150.00 | Unknown | Omeprazole | Unknown | NA | Stomach | Cirrhosis by alcohol since 2016 | U/A | |||||||||||||||||||||
| SST0000-CV900096302031819DD | Stomach Cancer | Vietnam | SST | 1.00 | 1.00 | $150.00 | 71 Y | Female | Non-Hispanic | <-70C | 18-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | N1M1 | Date N/A | Additional Notes | Endoscopy: tumor in stomach 1x1.5 cm, ucler. Pathology: adenocarcinoma. | $150.00 | Unknown | Omeprazole, Metformin | Postmenopausal | NA | Stomach | Hypertension, Diabetes | Abdominal lymph nodes | |||||||||||||||||||||
| SST0000-CV900098050050419DD | Stomach Cancer | Vietnam | SST | 1.00 | 1.00 | $150.00 | 71 Y | Male | Non-Hispanic | <-70C | 04-May-19 | Clinical Diagnosis | Stomach Cancer (Gastric) | Staging | IV TXN3M1 | 11-May-19 | Additional Notes | Endoscopy: tumor in stomach. Pathology: adenocarcinoma. CT Scan: multiple lesions in neck max. 3.0x2.5 cm | $150.00 | Unknown | None | Unknown | NA | Stomach | Hypertension > 10 years | Liver, Lymph nodes | |||||||||||||||||||||
| SST0000-CV900098054061819DD | Stomach Cancer | Vietnam | SST | 1.00 | 1.00 | $150.00 | 21 Y | Female | Non-Hispanic | <-70C | 18-Jun-19 | Clinical Diagnosis | Stomach Cancer | Staging | Iia T1bN2M0G3 | 3-Jun-19 | Additional Notes | Pathology: Adenocarcinoma. Endoscopy: ulcer 0.4 cm in stomach bulge. CT scan: normal | $150.00 | Unknown | Omeprazole | Premenopausal | NA | Stomach | None | Lymph nodes | |||||||||||||||||||||
| SST0000-CV900098695040419DD | Stomach Cancer | Vietnam | SST | 1.00 | 1.00 | $150.00 | 85 Y | Male | Non-Hispanic | <-70C | 04-Apr-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV T4N3M0G2 | 2-Apr-19 | Additional Notes | Pathology: Adenocarcinoma grade II. Endoscopy: tumor with ulcer | $150.00 | Unknown | None | Unknown | NA | Stomach | Hypertension | Abdominal lymph nodes | |||||||||||||||||||||
| SST0000-CV900398758030619D3 | Stomach Cancer | Vietnam | SST | 0.35 | 3.00 | $150.00 | 63 Y | Male | Non-Hispanic | <-70C | 06-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | II; T2NXM0 | Date of Primary Tumor Diagnosis | 2019-03-04 | $150.00 | Unknown | 2019-03-06 | Nexium | 65.75 | 117 | Stomach | None | U/A | No | CA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 | | |||||||||||||||||||
| SST0000-CV900398763030719D4 | Stomach Cancer | Vietnam | SST | 0.35 | 3.00 | $150.00 | 69 Y | Male | Non-Hispanic | <-70C | 07-Mar-19 | Clinical Diagnosis | Stomach Cancer | Staging | IV; T3N3MX | Date of Primary Tumor Diagnosis | 2019-02-25 | $150.00 | Unknown | 2019-03-07 | Omeprazole, Amlodipine | 62.60 | 128 | Stomach | Hypertension | Lymph nodes | No | CEA: 3.75 U/mL | 19-Feb-2019 | | |||||||||||||||||||
| STO0000-G2900354486111919DD | Stomach Cancer | Ukraine | Stool | 3.00 | 1.00 | Special Order. Please Inquire | 70 Y | Male | Non-Hispanic | <-70C | 19-Nov-19 | Staging | II | Stomach body cancer | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||
| STO0000-G2900355221111419DD | Stomach Cancer | Ukraine | Stool | 5.00 | 1.00 | Special Order. Please Inquire | 71 Y | Female | Non-Hispanic | <-70C | 14-Nov-19 | Staging | IV | Stomach Cancer | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||
| STO0000-G2900360124121619DD | Stomach Cancer | Ukraine | Stool | 8.00 | 1.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 16-Dec-19 | Diagnosis | Stomach Cancer, stage III | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||||||||
| STO0000-G2900371512121719DD | Stomach Cancer | Ukraine | Stool | 1.00 | 1.00 | $150.00 | 45 Y | Female | Non-Hispanic | <-70C | 17-Dec-19 | Diagnosis | Stomach cancer, stage III | $150.00 | Unknown | ||||||||||||||||||||||||||||||||
| STO0000-G2900371556112619DD | Stomach Cancer | Ukraine | Stool | 1.00 | 1.00 | $150.00 | 79 Y | Male | Non-Hispanic | <-70C | 26-Nov-19 | Staging | II | Stomach Cancer | $150.00 | Unknown | |||||||||||||||||||||||||||||||
| STO0000-G2900371557110419DD | Stomach Cancer | Ukraine | Stool | 1.00 | 1.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 04-Nov-19 | Staging | II | Stomach Cancer | $150.00 | Unknown | |||||||||||||||||||||||||||||||
| STO0000-G2900371558111419DD | Stomach Cancer | Ukraine | Stool | 1.00 | 1.00 | $150.00 | 44 Y | Female | Non-Hispanic | <-70C | 14-Nov-19 | Staging | III | Stomach Cancer | $150.00 | Unknown | |||||||||||||||||||||||||||||||
| STO0000-G2900388009012020DD | Stomach Cancer | Ukraine | Stool | 6.00 | 1.00 | Special Order. Please Inquire | 64 Y | Female | Non-Hispanic | <70C | 20-Jan-20 | Diagnosis | Stomach Cancer | Stomach Cancer | Special Order. Please Inquire | Unknown |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.